1-3 of 3
Sandip N. Chakraborty
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Jak2 Regulates Bcr-Abl In CD34+ Cells From Imatinib Mesylate-Resistant CML Patients.

Ajoy K. Samanta, Ph.D., Bastianella Perazzona, Ph.D., Sandip N. Chakraborty, Xiaoping Sun, MD, PhD, Hardik Modi, Ravi Bhatia, MD, Ralph B. Arlinghaus, PhD
Journal: Blood
Blood (2010) 116 (21): 1220.
https://doi.org/10.1182/blood.V116.21.1220.1220
Published: 2010
Journal Articles

Jak2 Phosphorylates Tyr 177 of Bcr-Abl Activating the Ras and PI-3 Kinase Pathways and Maintains Functional Levels of Bcr-Abl in Chronic Myelogenous Leukemia.

Ajoy K. Samanta, PhD, Sandip N. Chakraborty, Xiaoping Sun, M.D., Ph.D, Ellen Schlette, M.D., Waldemar Priebe, Ph.D., Ralph B. Arlinghaus, PhD
Journal: Blood
Blood (2009) 114 (22): 39.
https://doi.org/10.1182/blood.V114.22.39.39
Published: 2009
Journal Articles

Disruption of the Bcr-Abl/Jak2/HSP90 Network Complex Leading to Induction of Apoptosis in Drug-Resistant CML Cells by a New Compound WP1193

Ajoy K. Samanta, PhD, Sandip N. Chakraborty, Susmita Samanta, Ph.D., Yan Wang, M.D., Xiaoping Sun, MD, PhD, E. Schlette, Waldemar Priebe, Ph.D., Ralph B. Arlinghaus, PhD
Journal: Blood
Blood (2008) 112 (11): 3199.
https://doi.org/10.1182/blood.V112.11.3199.3199
Published: 2008